The Evolution of Therapeutic Options in ITP

  The Evolution of Therapeutic Options in ITP
 
  Title: The Evolution of Therapeutic Options in ITP
  Release Date: December 1, 2007
Expiration Date: December 31, 2008
(CME credit is no longer available for this activity)
  Originally presented at Cytopenias in 2007
San Diego, CA, October 5, 2007
  Agenda:

The Pathophysiology of Thrombopoiesis (9:23)   Amy Geddis, MD, PhD
Thrombopoietic-like Agents (23:39)   Terry Gernsheimer, MD
Mechanisms of Effects of IVIg and Intravenous Anti-D in ITP (11:20)   Alan H. Lazarus, PhD
Clinical Effects of IVIg and Anti-D in ITP (9:26)   James B. Bussel, MD
Clinical Effects of Rituximab: Targeting of B Cells (9:43)   Douglas B. Cines, MD
 
  Unrestricted Educational Grant Provided by:

GSK

  Jointly Sponsored by:

Dannemiller

Jonathan Wood & Associates

 
  This program is only available to registered users

If you have already registered, please click here to login and continue.
Otherwise, please click here to register first.